VIM and carcinoma: Similar to the proteomic study of cervical carcinomas (Bae et al, 2005), but in contrast to the findings in other carcinomas, we found a downregulation of vimentin in both vaginal and cervical carcinoma, suggesting alternative pathways for epithelial–mesenchymal transition.